No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy

P Baliakas, M Mattsson, A Hadzidimitriou, E Minga, A Agathangelidis, LA Sutton, L Scarfò, Z Davis, XJ Yan, K Plevova, Y Sandberg, FJ Vojdeman, T Tzenou, CC Chu, S Veronese, L Mansouri, KE Smedby, V Giudicelli, F Nguyen-Khac, P PanagiotidisG Juliusson, A Anagnostopoulos, MP Lefranc, L Trentin, M Catherwood, M Montillo, CU Niemann, AW Langerak, S Pospisilova, N Stavroyianni, N Chiorazzi, D Oscier, DF Jelinek, T Shanafelt, N Darzentas, C Belessi, F Davi, P Ghia, R Rosenquist, K Stamatopoulos

Research output: Contribution to journalArticle

Abstract

Abstract not available
Original languageEnglish
Pages (from-to)e158-e161
JournalHaematologica
Volume103
Issue number4
DOIs
Publication statusPublished - 2018

Fingerprint Dive into the research topics of 'No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy'. Together they form a unique fingerprint.

  • Cite this

    Baliakas, P., Mattsson, M., Hadzidimitriou, A., Minga, E., Agathangelidis, A., Sutton, LA., Scarfò, L., Davis, Z., Yan, XJ., Plevova, K., Sandberg, Y., Vojdeman, FJ., Tzenou, T., Chu, CC., Veronese, S., Mansouri, L., Smedby, KE., Giudicelli, V., Nguyen-Khac, F., ... Stamatopoulos, K. (2018). No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy. Haematologica, 103(4), e158-e161. https://doi.org/10.3324/haematol.2017.182634